beyondair.net (XAIR) - Koefisien utang jangka dawa marang modal

Beyond Air, Inc. (XAIR) relies on a streamlined equipment delivery system to clinics to ensure patient safety. After reviewing the long-term debt-to-equity ratio on GURU.Markets, we see that the metric has reached 11.59. This confirms the resilience of the business, which is protected by patents and strict FDA oversight, as well as proficient component inventory management to prevent disruptions.

Beyond Air, Inc. (XAIR) is developing the innovative LungFit cylinder-free technology, which requires significant R&D capital expenditures. The long-term debt-to-equity ratio compares obligations with maturities exceeding one year against net assets. This coefficient measures the degree of financial leverage and the extent to which development depends on external borrowings. Abnormal stability of this metric amid rising debt may signal hidden balance sheet manipulations. A low ratio confirms the resilience of the business model and the reliability of the investments.